Steve Henck

Steve Henck has extensive work experience in the pharmaceutical and healthcare industry. Steve currently holds the position of Vice President, Market Access & Channel Innovations at Pardes Biosciences since April 2022. Prior to that, they worked at Genentech, USA where they held the roles of Healthcare Executive Director from December 2019 to April 2022, and National Director, Federal Accounts from January 2018 to December 2019. Before joining Genentech, Steve was the National Director, Channel National Team at Genentech USA from November 2016 to January 2018. Steve also served as the National Director, BioOncology Account Management at Genentech USA, Inc. from October 2014 to November 2016, where they successfully managed a team in developing strategic relationships with academic cancer centers and large community-based oncology practices. Starting their career at Cardinal Health in 1995, Steve held various leadership positions including Vice President and General Manager, Pharmaceutical Trading from August 2003 to October 2005, and Vice President, Sales and Purchasing at Cardinal Health, Inc. from May 2002 to August 2003. Steve also worked as the National Account Director, Trade at Takeda Pharmaceuticals from September 2000 to May 2002. Steve began their career at Deloitte as a Senior Consultant from December 1993 to May 1995.

Steve Henck attended The Ohio State University Fisher College of Business from 1987 to 1993. During this time, they obtained a Bachelor of Science (BS) and a Master of Business Administration (MBA) degree. Their field of study was Business Administration and Management, with a focus on General Management.